Sundrug Co., Ltd. (9989) - Analysis

opens in 2d 8h 2m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.70 -0.10%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.04%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.70 -0.10%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.04%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.70 -0.10%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.04%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.70 -0.10%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.04%
XPT/USD 1,003.20 0.33%

Market closed

Access this stock data via API

Sundrug Co., Ltd.

0

0

0%

Analysis

Revenue estimate	Next quarter (Jun 2026)	Next year (Mar 2027)
Number of Analysts	1	7
Avg. estimate	218B	922.01B
Low estimate	218B	885.50B
High estimate	218B	977B
Last year sales	207.70B	851.66B
Sales growth	0.05	0.08

Access /revenue_estimate data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

EPS revisions	Next quarter (Jun 2026)	Next year (Mar 2027)
Up last 7 days	0	0
Up last 30 days	0	0
Down last 7 days	0	0
Down last 30 days	0	3

Access /eps_revisions data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Recommendation

Buy

42.9%

Neutral

28.6%

Buy

28.6%

Strong buy

Access /recommendations data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.